18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
Open Access
- 1 June 2003
- Vol. 52 (90004) , 23iv-29
- https://doi.org/10.1136/gut.52.suppl_4.iv23
Abstract
Positron emission tomography with 18F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.Keywords
This publication has 71 references indexed in Scilit:
- Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.2000
- Positron emission tomography scanning in the evaluation of hepatocellular carcinomaJournal of Hepatology, 2000
- Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomographyDiseases of the Colon & Rectum, 2000
- Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.1999
- Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastasesThe American Journal of Surgery, 1999
- Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.Radiology, 1998
- Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission TomographyThe Annals of Thoracic Surgery, 1997
- Staging recurrent metastatic colorectal carcinoma with PET.1997
- Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997